Peer review reports
From: Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma
| Original Submission |
| 20 Sep 2023 |
Submitted |
Original manuscript
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
| 23 Oct 2023 |
Author responded |
Author comments - Feng Jin
|
| Resubmission - Version 4 |
| 23 Oct 2023 |
Submitted |
Manuscript version 4
|
| 25 Oct 2023 |
Author responded |
Author comments - Feng Jin
|
| Resubmission - Version 5 |
| 25 Oct 2023 |
Submitted |
Manuscript version 5
|
| 8 Nov 2023 |
Author responded |
Author comments - Feng Jin
|
| Resubmission - Version 6 |
| 8 Nov 2023 |
Submitted |
Manuscript version 6
|
| 24 Apr 2024 |
Reviewed |
Reviewer Report
|
| 25 Apr 2024 |
Reviewed |
Reviewer Report
|
| 30 Apr 2024 |
Author responded |
Author comments - Feng Jin
|
| Resubmission - Version 7 |
| 30 Apr 2024 |
Submitted |
Manuscript version 7
|
| Publishing |
| 2 May 2024 |
Editorially accepted |
|
| 6 May 2024 |
Article published |
10.1186/s12865-024-00621-3
|
Learn about peer review
